Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclical vs Standard Interferon Beta-1b in MS
NCT00270816Phase 3Completed
- Sponsor
- Sant'Andrea Hospital
- Start
- Nov 2005
- Primary completion
- Aug 2010
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of interferon beta-1b in multiple sclerosis (MS) (2 arms), sponsored by Sant'Andrea Hospital. Primary endpoint: Number of gad-enhancing lesions (CELs) in T1 at 12 months. Started Nov 2005; status: completed.
02
Drugs
interferon beta-1b
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00270816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00270816.